These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 32471179)
1. Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction? Dai L; Meijers BK; Bammens B; de Loor H; Schurgers LJ; Qureshi AR; Stenvinkel P; Evenepoel P Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32471179 [TBL] [Abstract][Full Text] [Related]
2. The role of kidney transplantation and phosphate binder use in vitamin K status. Jansz TT; Neradova A; van Ballegooijen AJ; Verhaar MC; Vervloet MG; Schurgers LJ; van Jaarsveld BC PLoS One; 2018; 13(8):e0203157. PubMed ID: 30161193 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001 [TBL] [Abstract][Full Text] [Related]
4. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk. Rapp N; Brandenburg VM; Kaesler N; Bakker SJL; Stöhr R; Schuh A; Evenepoel P; Schurgers LJ Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684491 [TBL] [Abstract][Full Text] [Related]
5. Vitamin K status and mortality after kidney transplantation: a cohort study. Keyzer CA; Vermeer C; Joosten MM; Knapen MH; Drummen NE; Navis G; Bakker SJ; de Borst MH Am J Kidney Dis; 2015 Mar; 65(3):474-83. PubMed ID: 25453995 [TBL] [Abstract][Full Text] [Related]
6. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease. Glorieux G; Gryp T; Perna A Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429 [TBL] [Abstract][Full Text] [Related]
7. Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients? Lenglet A; Fabresse N; Taupin M; Gomila C; Liabeuf S; Kamel S; Alvarez JC; Drueke TB; Massy ZA Drugs; 2019 Jun; 79(8):855-862. PubMed ID: 31062264 [TBL] [Abstract][Full Text] [Related]
8. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk. Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228 [TBL] [Abstract][Full Text] [Related]
9. Pleiotropic effects of the non-calcium phosphate binder sevelamer. Nikolov IG; Joki N; Maizel J; Lacour B; Drüeke TB; Massy ZA Kidney Int Suppl; 2006 Dec; (105):S16-23. PubMed ID: 17136111 [TBL] [Abstract][Full Text] [Related]
10. Associations of vitamin K status with mortality and cardiovascular events in peritoneal dialysis patients. Xu Q; Guo H; Cao S; Zhou Q; Chen J; Su M; Chen S; Jiang S; Shi X; Wen Y Int Urol Nephrol; 2019 Mar; 51(3):527-534. PubMed ID: 30689181 [TBL] [Abstract][Full Text] [Related]
11. Uremic toxins and oral adsorbents. Goto S; Yoshiya K; Kita T; Fujii H; Fukagawa M Ther Apher Dial; 2011 Apr; 15(2):132-4. PubMed ID: 21426503 [TBL] [Abstract][Full Text] [Related]
12. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients. Boxma PY; van den Berg E; Geleijnse JM; Laverman GD; Schurgers LJ; Vermeer C; Kema IP; Muskiet FA; Navis G; Bakker SJ; de Borst MH PLoS One; 2012; 7(10):e47991. PubMed ID: 23118917 [TBL] [Abstract][Full Text] [Related]
13. Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease. Evenepoel P; Claes K; Meijers B; Laurent M; Bammens B; Naesens M; Sprangers B; Pottel H; Cavalier E; Kuypers D J Bone Miner Res; 2019 Feb; 34(2):262-269. PubMed ID: 30427544 [TBL] [Abstract][Full Text] [Related]
14. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Kremer D; Groothof D; Keyzer CA; Eelderink C; Knobbe TJ; Post A; van Londen M; Eisenga MF; TransplantLines Investigators ; Schurgers LJ; Berger SP; de Borst MH; Bakker SJL Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578950 [TBL] [Abstract][Full Text] [Related]
15. Gut Microbiome-Derived Uremic Toxin Levels in Hemodialysis Patients on Different Phosphate Binder Therapies. Wang LC; Tapia LM; Tao X; Chao JE; Thwin O; Zhang H; Thijssen S; Kotanko P; Grobe N Blood Purif; 2022; 51(8):639-648. PubMed ID: 34375976 [TBL] [Abstract][Full Text] [Related]
17. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K Aoun M; Makki M; Azar H; Matta H; Chelala DN BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319 [TBL] [Abstract][Full Text] [Related]
18. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635 [TBL] [Abstract][Full Text] [Related]
19. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease. Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433 [TBL] [Abstract][Full Text] [Related]
20. Thrombolome and Its Emerging Role in Chronic Kidney Diseases. Fryc J; Naumnik B Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]